| INTRODUCTION
Lymph node (LN) fine needle cytology (FNC) may be performed in different clinic settings with different diagnostic needs; it can be performed in different anatomic sites and at different times on the same patient. LN-FNC can be guided in different ways, including palpation, ultrasound (US), computed tomography (CT) and oesophageal ultrasound-endobronchial ultrasound (OUS-EBUS), which may affect the quantity and quality of cell yield. The range of pathologies that LN-FNC may deal with is wide and ancillary techniques, in addition to traditional smears, may be required to reach a final diagnosis.
However, to obtain consistent and accurate immunocytochemistry (ICC), fluorescence in situ hybridisation (FISH), flow cytometry (FC) or molecular results, using the most effective vials, fixatives and technical devices (e.g.: additional smears, cytospin slides, LBC slides, cards, resins, etc). is essential, since they may perform differently with different ancillary techniques, and even in different pathologies.
These difficulties may be further enhanced by the generally small size of the sample and the different ways of acquisition of the cytologic sample. Therefore, accurate control and standardisation of all the variables affecting the preanalytic phase of LN-FNC is mandatory. It is also essential to standardise procedures and diagnostic algorithms in clinic practice to maximise the potential information of each technique.
1 Therefore, ancillary techniques, vials and devises have to be chosen on the basis of the specific pathologies, diagnostic needs and characteristics of the yielded material. LN-FNC should ideally provide cells to be stored for further investigations, specifically for molecular testing. Considering these factors, LN-FNC requires a specific approach that is quite different from that used for FNC of any other organ or pathology. Moreover, the amount of material obtained by FNC is limited and, therefore, it has to be exploited to the maximum by transferring such material into vials or any other devise that better matches the selected ancillary technique. For this purpose, FNC should be performed by a cytopathologist with rapid on-site evaluation (ROSE) for the optimal management of the diagnostic material and overall for an effective LN-FNC. 2, 3 The main devises and vials used for LN-FNC are airdried or alcohol-fixed smears, buffered mediums (phosphate buffered saline [PBS] , CytoLyt, RNA-later etc.) and formalin. [4] [5] [6] [7] [8] [9] The most frequently used ancillary techniques are FC, 10-17 ICC, [20] [21] [22] [23] [24] [25] [26] [27] FISH 60, 61 and molecular tests. [62] [63] [64] [65] [66] [67] [68] [69] As far as cell storage is concerned, whereas genetic material can be obtained by any technical devise, cryostorage is the best procedure to store LN-FNC cells, as well as other cells and tissues. [70] [71] [72] [73] [74] [75] [76] [77] Recently, special FTA ® cards
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have been used to store genetic material. [70] [71] [72] [73] [74] [75] [76] [77] Each device or vial is characterised by specific features that fit with each of these ancillary techniques; conversely, ancillary techniques may be applied to cells on several or single technical devices. Choosing one device over another is important for LN-FNC, as well as using one technique over another. The following factors should also be considered:
experience of the laboratory; availability of techniques; quality of the obtained sample (cellularity, blood contamination); antibodies or probes to be used; cell targets (nuclear, membrane or cytoplasmic);
presence of other cellular elements (residual lymphoid population, histiocytes, necrosis); and size of cells to be studied. This review investigates the management of LN-FNC material, vials, technical devices and main ancillary techniques in the main LN pathologic processes, with exclusion of metastatic lung cancer that is described in a different review of the present issue. We also describe the optimal application of the above items by taking into account the different diagnostic needs and cell storage. The application and performance of ancillary techniques in each of the different groups of LN pathologies are outlined in independent sections ( Figure 1 ).
The main uses of different technical procedures, according to the different LN pathologies, is detailed in Table 1 .
| CELL BLOCK
Cell block (CB) procedures are the most used and validated methods for ancillary techniques in LN-FNC, including immunostains, molecular assays and archival purposes. Several methods can be used to set up CBs, 4,5 which use different agents to congeal pellets (gelatine, plasma thrombin, agar, histogel and acrylic resin) and a variety of fixatives.
4-7
Cell suspensions are generally fixed in formalin before being transferred to pellets or they may be postfixed in formalin after a previous fixation with alcohol-based fixatives, as with liquid-based cytology 
| Reactive hyperplasia
Reactive LNs are the most common target of LN-FNC; conventional smears, combined with clinic and ultrasound data, may lead to a diagnosis in a number of cases. Ancillary techniques may be required in case of a differential diagnosis with low-grade non-Hodgkin lymphomas (NHL), or when there is a need to look for dense groups on smears and search for diagnostic cells in suspected Hodgkin's lymphoma or to exclude micrometastases, in case of a previously known neoplasia. In reactive processes with follicular expansion, the differential diagnosis is generally with a follicular lymphoma (FL). The latter will often depend on the quantification of cell phenotypes mainly performed by FC, 10-17 ICC on cytospins [20] [21] [22] [23] [24] [25] or LBC. [26] [27] [28] [29] There are few large series in the literature on the use of CB in reactive processes, compared to the lymphoma diagnosis, claiming high sensitivity and specificity for LN-FNC of lymphoma diagnosis.
9, [30] [31] [32] CB can also be used for utilising special stains for specific lymphadenopathies, such as silver and Ziehl-Neelsen staining. [33] [34] [35] Furthermore, CB may be used to detect specific antigens by means of ICC when cultural examination or staining on fresh material cannot be performed. In the case of specific lymphadenopathies, the examination of CB sections prepared from tissue fragments present in the aspirated material allows observation of the whole morphology of the lesion because the architectural relationship of the different cell types is preserved. This is the case with Kikuchi's disease, 36 Castleman's disease 37 and lymphadenopathies with a granulomatous pattern. 38 CB has been successfully used in LN-FNC of sarcoidosis and other granulomatous processes on superficial or deeply located LNs (mainly mediastinal) by OUS-EBUS. 38 The main weaknesses of CBs are the scanty cellularity and the occasional absence of tissue fragments. 59 Direct smears and cytospins are generally preferred for FISH using dedicated or even destained slides, probably because of the nuclear integrity of these samples. CB has been used for FISH identification of the IGH-BCL2 and c-MYC rearrangement in the double-hit NHL. 40 With reference to molecular testing, CB has been rarely used for specific tests such as immunoglobulin heavy chain (IgH) or T cell receptor (TCR) rearrangements, probably because of the scanty amount of DNA that could be obtained; IgH or TCR rearrangements were usually performed on the residual material of cell suspensions. 
| Melanoma
LN-FNC is an accurate method for the diagnosis of metastatic melanoma and for the follow-up protocol of high-risk melanoma patients. In up to 20% of cases, LN metastases and subsequently FNC diagnosis of metastatic melanoma are the first clinic manifestation of the disease, without a known primary lesion. 84, 85 In these cases, due to the high variability of cytologic presentation, morphology alone may not be sufficient for a proper diagnosis, even in patients with a known history of melanoma, thus expanding the differential diagnosis. In these cases, the use of ancillary techniques enables the diagnosis and facilitates patient management 85 ( Figure 2 ). Moreover, as constitutively activating mutations in the BRAF oncogene are present in at least 40% of melanomas, patients with advanced-stage melanoma harbouring a BRAF mutation are candidates for BRAF inhibition as therapeutic strategy and FNC material can be used to evaluate the BRAF mutational status.
In the few studies dealing with LN-FNC of metastatic melanoma, DNA was purified from Diff-Quik ® -stained direct smears. 86, 87 For this purpose, CB material is a valid technical device for ICC studies and to perform ancillary molecular tests that can provide useful insights and targeted chemotherapeutic options (Figure 2 ). and SurePath (an ethanol-formaldehyde solution) are both fixatives.
| CYTOSPINS AND LBC
Cytospin technique is a centrifugation technique through which cell suspensions are spun onto a microscope slide by centrifugal force.
The fluid from the suspension is absorbed onto filter paper while the centrifuge is spinning and blood proteins, immunoglobulins and cell debris are absorbed, providing clean and monolayered samples for ICC and FISH. Several slides can be prepared, based on the cellularity of the sample. Cytospin slides can be fixed and stored in several ways: they can be placed in coated slides to prevent cells from peeling while ICC is performed; they can be air-dried overnight, and ICC can be performed the next morning; they can be immediately fixed in alcohol 95% and stained in Giemsa, haematoxylin-eosin or Papanicolaou; or, after being stained, they can also be reused for ICC ( Figure   3 ). Moreover, slides can also be frozen for 3 months at -20 to -80°C, after being fixed in acetone for 10 minutes, and then reused for ICC.
In the BD SurePath ™ method, the sample is vortexed, strained, layered onto a density gradient and centrifuged. In the ThinPrep-Hologic In these cases, the specific binding of antibodies to fragile cytoplasm of neoplastic cells may be hampered by degeneration or necrosis. 
| NHL and HL

| Cryostorage
Cryostorage has been used for tissue and cell storage for many years; it is the best cryopreservation system because it keeps cell antigenicity and DNA and RNA integrity, thus avoiding the coagulation of proteins caused by alcohol-based fixatives and cross-links between proteins and nucleic acids. Moreover, cryostorage preserves almost all the genetic material; by contrast, up to 30% of nucleic acids may be lost during fixation. 
